Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;16(6):365-8.

Severe hypophosphatemia in hospitalized patients

Affiliations
  • PMID: 2089250

Severe hypophosphatemia in hospitalized patients

M A Camp et al. Miner Electrolyte Metab. 1990.

Abstract

Although severe hypophosphatemia has been associated with significant morbidity, little quantitative information is available on the magnitude of the risk. The objective of this study was to determine the frequency and timing of severe hypophosphatemia, the relative risk associated with various medical diagnoses, and the choice of therapy. Among 10,197 patients hospitalized over a 1-year period, the incidence of severe hypophosphatemia (serum phosphate less than or equal to 0.33 mmol/l) was 0.43%. The incidence was 0.91% in alcoholics, 2.42% in septic patients, 10.4% in patients with malnutrition, and 14.6% in patients with diabetic ketoacidosis. The odds ratio for developing the metabolic abnormality was 4.2 (95% confidence interval 2.2-8.1) in alcoholics, 6.4 (1.9-18.9) in septic patients, 46.9 (16.6-125.6) in patients with diabetic ketoacidosis, and 60.7 (31.4-117.5) in malnourished patients. There was a 4-fold increase in mortality in patients with severe hypophosphatemia (18.2 vs. 4.6%; p less than 0.001). The metabolic abnormality was not recognized or was inappropriately treated in 42% of patients. Severe hypophosphatemia is a relatively common finding in hospitalized patients, especially in those with certain well-defined medical conditions. It is associated with significant excess mortality. Its recognition and treatment remain suboptimal.

PubMed Disclaimer